A message from our friends at Huge Alerts 
From Niche Regenerative Player to Scalable MedTech Contender: BioStem (BSEM) Combines Clinical Validation, Strong Margins, and Strategic Expansion for 2026 Growth! BioStem Technologies, Inc. (BSEM) has rapidly transitioned from a niche regenerative medicine company into a broader MedTech platform with expanding commercial reach and validated clinical performance. Its proprietary BioREtain® technology has demonstrated superior outcomes in wound healing through Level 1 clinical data, helping drive adoption across key channels like the VA system, Medicaid programs, and ambulatory care centers. With demand continuing to build—even amid pricing headwinds—the company is showing it can scale effectively in a competitive and evolving market. A Nasdaq uplisting potentially on the horizon and analyst coverage pointing to valuation upside, BioStem is increasingly difficult to ignore. The recent BioTissue asset acquisition adds another layer of growth by immediately contributing revenue and opening doors to hospital-based care, while also enhancing BSEM’s sales infrastructure. At the same time, its strong margin profile and history of profitability distinguish it from peers still reliant on external funding. With a $25.50 price target from Zacks Small Cap Research, BSEM’s current valuation highlights a notable disconnect between market pricing and underlying fundamentals. Learn why BSEM is gaining traction as a high-conviction name in small-cap MedTech
Exclusive Article from MarketBeat.com Berkshire, Broadcom & Nucor Are Revving Their Buyback EnginesSubmitted by Leo Miller. Article Published: 3/16/2026. 
Key Points - Berkshire Hathaway is signaling that its shares are below their intrinsic value as it restarts buyback spending.
- Chips giant Broadcom likely sees something similar in its stock as the firm's buyback activity is picking up big-time.
- Steel giant Nucor has surged over the past 52 weeks and now has large buyback capacity.
- Special Report: Have $500? Invest in Elon's AI Masterplan
 Two stocks with market capitalizations over $1 trillion and North America's top dog in steel production just made significant buyback announcements. All three companies are signaling confidence in their outlooks, with Berkshire Hathaway, the world's largest financial services company, clearly indicating it believes investors are undervaluing the business. Berkshire Announces Resumption of Buybacks After Almost Two-Year Hiatus Warren Buffett's Berkshire Hathaway (NYSE: BRK.B) is one of the most renowned investment firms in history and one of just 12 companies globally with a market capitalization above $1 trillion. It is also the only financial services firm in that group. I Met Elon Musk "Face-to-Face" During a private gathering of Wall Street elites, I was one of two people selected to speak with Elon personally. As a result, my research now leads me to believe Elon will announce the SpaceX IPO on this date: March 26, 2026. Circle it on your calendar. I'm sharing an "access code" that lets anyone grab a pre-IPO stake before it happens. This is your invitation to the biggest wealth-building event of the decade. Click Here to See how to Get Your "SpaceX Access Code" Despite its historic success, the stock has stumbled recently: shares have fallen after each of the past four earnings reports, including a nearly 5% drop after the most recent release. This weakness followed a quarter in which the company missed estimates, with operating earnings down 30%. The decline was driven largely by a soft insurance segment, where underwriting earnings fell 54%. Over the past 52 weeks, Berkshire shares have been essentially flat to slightly down. Unlike many companies, Berkshire does not announce buyback authorizations tied to a specific dollar amount. A 2018 amendment to its buyback policy permits repurchases whenever management determines shares are "below Berkshire's intrinsic value, conservatively determined." The company evidently reached that conclusion in early 2026. In a recent SEC filing, the firm said: "We are disclosing that we commenced repurchasing shares of our common stock under this policy on Wednesday, March 4, 2026." The scale of the repurchases has not been disclosed, but the filing makes clear Berkshire sees value in its shares; the firm had not repurchased stock since mid-2024. AVGO Undertakes Huge Buyback Spending and Reloads Its Buyback Program Semiconductor behemoth Broadcom (NASDAQ: AVGO), another member of the $1 trillion club, is also turning up its buyback activity. Broadcom's results have been strong, driven by demand for its artificial intelligence (AI) solutions. In its latest quarter, the company beat estimates on both revenue and adjusted earnings per share and provided guidance that exceeded expectations. Broadcom also said it sees a path to generating over $100 billion in AI revenue in fiscal 2027, roughly aligned with the 2027 calendar year. For context, $100 billion would be roughly 46% more than the $68.3 billion in total revenue the firm generated over the last 12 months. That AI figure does not include non-AI semiconductor sales or Broadcom's infrastructure software businesses, which together accounted for 56% of total revenue last quarter. Despite this outlook, Broadcom shares remain about 20% below their all-time high. Broadcom's buyback activity suggests management believes the market is underestimating the company. Last quarter the firm repurchased $7.8 billion of stock, its second-largest quarterly buyback on record, following two quarters with little repurchase activity. The company then announced a $10 billion repurchase authorization. While that amount represents less than 1% of the company's approximately $1.5 trillion market capitalization, it is a meaningful signal of confidence. The authorization runs only through the end of 2026, which implies Broadcom intends to act relatively quickly to take advantage of the share-price weakness. NUE's Buyback Capacity Exceeds 10% as Shares Put Up Impressive Gains Last up is Nucor (NYSE: NUE), a giant in North American steel production. Based on 2024 data, Nucor produced more steel than any other North American company. Global production is dominated by firms in Asia, however, placing Nucor outside the top 10 worldwide. Nucor stock has performed well over the past 52 weeks, delivering a total return of roughly 25%. Several factors have favored Nucor. Steel tariffs have reduced U.S. imports from foreign competitors, supporting demand for domestic production. Nucor notes the foreign share of the U.S. finished steel market was near 25% at the start of 2025 and had fallen to an estimated 14% by November 2025. The company expects that percentage to remain steady or decline further in 2026. Demand across Nucor's key end markets — including infrastructure, data centers, and energy — remains strong. Those dynamics helped Nucor enter 2026 with what management calls "historically strong backlogs." Its steel mill backlog rose 40% year over year, while its steel products backlog increased 15%. Against that backdrop, Nucor announced a $4 billion share buyback program. That program equals almost 11% of the company's roughly $37 billion market capitalization, giving Nucor meaningful capacity to return capital to shareholders over time. AVGO's Buybacks Signal Undervaluation as AI Demand Explodes Among these moves, Broadcom's recent surge in repurchases and its new authorization stand out. Management appears to believe the company's results and forward outlook justify a faster pace of buybacks given the stock's decline. For an AI-infrastructure leader, those are notable confidence signals. | 
